StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > $5 million in 2 quarters

<< Previous

Bullboard Posts

Next >>

Post by LithLoveron Apr 12, 2021 12:57pm

136 Views

Post# 32978005

$5 million in 2 quarters

Q3 and Q4. Could we see another $10 million in Q1 and Q2? They are going to be beasts and we have $7 million in cash. We are cashed up with revenue coming in.

Yeah things are dire. LOL

Love to see all the bashing and naked shorts it will just make the squeeze that much sweeter. It will come by Q1 results release if not sooner.

Mkae some new accounts. Keep going you are making your family proud.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages